focus -WSS

focus

author：fashion 2025-09-06 02:04:24 - browse：29371

Sammy Kimball for STAT

Can unicorns survive without data? Did biotech get over its skis? And what is going on at Biogen?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Allison DeAngelis joins us to share her reporting on how the handsomely funded Laronde Therapeutics, billed as “Moderna 2.0,” ran into behind-the-scenes problems with its scientific data. We also discuss how Biogen’s boardroom scandal has roiled a company that was supposed to be entering a new era.

For more on what we cover, here’s the Laronde story; here’s the latest on Biogen; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Cancer drug shortages should be causing more outrage
Next article： Another man arrested in connection with shooting at Kansas nightclub

WSS

Sen. Bill Cassidy on how to lower drug prices

FDA approves first new drug developed for postpartum depression

Another man arrested in connection with shooting at Kansas nightclub

With fresh data, a dynamic duo powers Eli Lilly to new heights

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Patients, doctors are clashing about side effects of hormonal birth control

focus

focus

explore

Jerome Adams on the need for new antivirals for Covid

Xenotransplantation trials will require adjusting expectations, experts say

Affirmative action in medical school literally saved lives

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

Tori Bowie and the unacceptable rates of Black maternal death

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Psychedelics group wrestles with new pharma identity

Reanimated hearts work just as well for transplants, study finds

As demand for Covid shots wanes, Moderna seeks its next success

Can medical device makers keep up in the race to treat obesity?

focus

The PBM ad wars are taking over Washington, D.C.

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Biden administration plans revamp of organ transplant system

Biden administration plans revamp of organ transplant system

Biogen nominates mother of director’s child to replace him on board

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

focus

explore

leisure time

knowledge